{
     "PMID": "25649132",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20160201",
     "LR": "20150204",
     "IS": "2041-1723 (Electronic) 2041-1723 (Linking)",
     "VI": "6",
     "DP": "2015 Feb 4",
     "TI": "KCNQ5 K(+) channels control hippocampal synaptic inhibition and fast network oscillations.",
     "PG": "6254",
     "LID": "10.1038/ncomms7254 [doi]",
     "AB": "KCNQ2 (Kv7.2) and KCNQ3 (Kv7.3) K(+) channels dampen neuronal excitability and their functional impairment may lead to epilepsy. Less is known about KCNQ5 (Kv7.5), which also displays wide expression in the brain. Here we show an unexpected role of KCNQ5 in dampening synaptic inhibition and shaping network synchronization in the hippocampus. KCNQ5 localizes to the postsynaptic site of inhibitory synapses on pyramidal cells and in interneurons. Kcnq5(dn/dn) mice lacking functional KCNQ5 channels display increased excitability of different classes of interneurons, enhanced phasic and tonic inhibition, and decreased electrical shunting of inhibitory postsynaptic currents. In vivo, loss of KCNQ5 function leads to reduced fast (gamma and ripple) hippocampal oscillations, altered gamma-rhythmic discharge of pyramidal cells and impaired spatial representations. Our work demonstrates that KCNQ5 controls excitability and function of hippocampal networks through modulation of synaptic inhibition.",
     "FAU": [
          "Fidzinski, Pawel",
          "Korotkova, Tatiana",
          "Heidenreich, Matthias",
          "Maier, Nikolaus",
          "Schuetze, Sebastian",
          "Kobler, Oliver",
          "Zuschratter, Werner",
          "Schmitz, Dietmar",
          "Ponomarenko, Alexey",
          "Jentsch, Thomas J"
     ],
     "AU": [
          "Fidzinski P",
          "Korotkova T",
          "Heidenreich M",
          "Maier N",
          "Schuetze S",
          "Kobler O",
          "Zuschratter W",
          "Schmitz D",
          "Ponomarenko A",
          "Jentsch TJ"
     ],
     "AD": "1] Leibniz-Institut fur Molekulare Pharmakologie (FMP), Robert-Rossle-Street 10, Berlin 13125, Germany [2] Max-Delbruck-Centrum fur Molekulare Medizin (MDC), Robert-Rossle-Street 10, Berlin 13125, Germany [3] Klinik fur Neurologie, Charite Universitatsmedizin, Chariteplatz 1, Berlin 10117, Germany. 1] Leibniz-Institut fur Molekulare Pharmakologie (FMP), Robert-Rossle-Street 10, Berlin 13125, Germany [2] NeuroCure Cluster of Excellence, Charite Universitatsmedizin, Chariteplatz 1, Berlin 10117, Germany. 1] Leibniz-Institut fur Molekulare Pharmakologie (FMP), Robert-Rossle-Street 10, Berlin 13125, Germany [2] Max-Delbruck-Centrum fur Molekulare Medizin (MDC), Robert-Rossle-Street 10, Berlin 13125, Germany. Neurowissenschaftliches Forschungszentrum, Charite Universitatsmedizin, Chariteplatz 1, Berlin 10117, Germany. 1] Leibniz-Institut fur Molekulare Pharmakologie (FMP), Robert-Rossle-Street 10, Berlin 13125, Germany [2] Max-Delbruck-Centrum fur Molekulare Medizin (MDC), Robert-Rossle-Street 10, Berlin 13125, Germany. Leibniz-Institut fur Neurobiologie (LIN), Brenneckestrasse 6, Magdeburg 39118, Germany. Leibniz-Institut fur Neurobiologie (LIN), Brenneckestrasse 6, Magdeburg 39118, Germany. 1] NeuroCure Cluster of Excellence, Charite Universitatsmedizin, Chariteplatz 1, Berlin 10117, Germany [2] Neurowissenschaftliches Forschungszentrum, Charite Universitatsmedizin, Chariteplatz 1, Berlin 10117, Germany [3] Deutsches Zentrum fur Neurodegenerative Erkrankungen in der Helmholtz-Gemeinschaft (DZNE), Charite Universitatsmedizin, Chariteplatz 1, Berlin 10117, Germany. 1] Leibniz-Institut fur Molekulare Pharmakologie (FMP), Robert-Rossle-Street 10, Berlin 13125, Germany [2] NeuroCure Cluster of Excellence, Charite Universitatsmedizin, Chariteplatz 1, Berlin 10117, Germany. 1] Leibniz-Institut fur Molekulare Pharmakologie (FMP), Robert-Rossle-Street 10, Berlin 13125, Germany [2] Max-Delbruck-Centrum fur Molekulare Medizin (MDC), Robert-Rossle-Street 10, Berlin 13125, Germany [3] NeuroCure Cluster of Excellence, Charite Universitatsmedizin, Chariteplatz 1, Berlin 10117, Germany.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20150204",
     "PL": "England",
     "TA": "Nat Commun",
     "JT": "Nature communications",
     "JID": "101528555",
     "RN": [
          "0 (KCNQ Potassium Channels)",
          "0 (KCNQ5 channel, mouse)"
     ],
     "SB": "IM",
     "MH": [
          "Action Potentials",
          "Animals",
          "GABAergic Neurons/metabolism",
          "Hippocampus/*metabolism",
          "Interneurons/metabolism",
          "KCNQ Potassium Channels/*metabolism",
          "Mice, Inbred C57BL",
          "Nerve Net/*physiology",
          "Neural Inhibition/*physiology",
          "Protein Transport",
          "Pyramidal Cells/metabolism",
          "Synapses/*metabolism",
          "Synaptic Transmission"
     ],
     "EDAT": "2015/02/05 06:00",
     "MHDA": "2016/02/02 06:00",
     "CRDT": [
          "2015/02/05 06:00"
     ],
     "PHST": [
          "2014/06/23 00:00 [received]",
          "2015/01/09 00:00 [accepted]",
          "2015/02/05 06:00 [entrez]",
          "2015/02/05 06:00 [pubmed]",
          "2016/02/02 06:00 [medline]"
     ],
     "AID": [
          "ncomms7254 [pii]",
          "10.1038/ncomms7254 [doi]"
     ],
     "PST": "epublish",
     "SO": "Nat Commun. 2015 Feb 4;6:6254. doi: 10.1038/ncomms7254.",
     "term": "hippocampus"
}